Clinical trial
French Prospective Observational Study In Intensive Care Unit (ICU) Patients Treated With Tigecycline
NCT00799591 is registered in ClinicalTrials.gov with Wyeth is now a wholly owned subsidiary of Pfizer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- French Prospective Observational Study In Intensive Care Unit (ICU) Patients Treated With Tigecycline
- Lead sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 30, 2008
- Completion date
- May 31, 2010
- Enrollment
- 156 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.